Cumberland Pharmaceuticals Inc. Net Income
Cumberland Pharmaceuticals Inc. (CPIX) reported Net Income of -$4.28 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-07
- Cumberland Pharmaceuticals Inc. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$4.28M.
- Cumberland Pharmaceuticals Inc. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$3.29M, a 361.69% decline year-over-year.
- Cumberland Pharmaceuticals Inc. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$1.41M.
- Cumberland Pharmaceuticals Inc. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$1.94M.
- Cumberland Pharmaceuticals Inc. net income (loss) attributable to parent for fiscal 2025 was -$2.84M.
- Cumberland Pharmaceuticals Inc. net income (loss) attributable to parent for fiscal 2024 was -$6.48M.
- Cumberland Pharmaceuticals Inc. net income (loss) attributable to parent for fiscal 2023 was -$6.28M.
- Cumberland Pharmaceuticals Inc. net income (loss) attributable to parent for fiscal 2022 was -$5.57M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.28M 10-Q · filed 2026-08-07 | -$7.57M 10-Q · filed 2026-08-07 | -$8.98M derived: sum of 3 quarters · filed 2026-08-07 | -$10.92M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | -$3.29M 10-Q · filed 2026-05-08 | -$4.70M derived: sum of 2 quarters · filed 2026-05-08 | -$6.64M derived: sum of 3 quarters · filed 2026-05-08 | -$7.38M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-12-31 | -$1.41M 10-K · filed 2026-03-09 | -$3.35M derived: sum of 2 quarters · filed 2026-03-09 | -$4.09M derived: sum of 3 quarters · filed 2026-08-07 | -$2.84M 10-K · filed 2026-03-09 | ||
| 2025-09-30 | -$1.94M 10-K · filed 2026-03-09 | -$2.68M derived: sum of 2 quarters · filed 2026-08-07 | -$1.42M 10-Q · filed 2025-11-07 | -$3.33M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-06-30 | -$740.74K 10-Q · filed 2026-08-07 | $516.33K 10-Q · filed 2026-08-07 | -$1.39M derived: sum of 3 quarters · filed 2026-08-07 | -$2.93M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $1.26M 10-Q · filed 2026-05-08 | -$646.75K derived: sum of 2 quarters · filed 2026-05-08 | -$2.19M derived: sum of 3 quarters · filed 2026-05-08 | -$3.28M derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2024-12-31 | -$1.90M 10-K · filed 2026-03-09 | -$3.45M derived: sum of 2 quarters · filed 2026-03-09 | -$4.53M derived: sum of 3 quarters · filed 2026-03-09 | -$6.48M 10-K · filed 2026-03-09 | ||
| 2024-09-30 | -$1.54M 10-K · filed 2026-03-09 | -$2.63M derived: sum of 2 quarters · filed 2026-03-09 | -$4.58M 10-Q · filed 2025-11-07 | -$10.87M derived: sum of 4 quarters · filed 2026-03-09 | ||
| 2024-06-30 | -$1.09M 10-K · filed 2026-03-09 | -$3.03M 10-Q · filed 2025-08-08 | -$9.33M derived: sum of 3 quarters · filed 2026-03-09 | -$10.38M derived: sum of 4 quarters · filed 2026-03-09 | ||
| 2024-03-31 | -$1.95M 10-K · filed 2026-03-09 | -$8.24M derived: sum of 2 quarters · filed 2026-03-09 | -$9.29M derived: sum of 3 quarters · filed 2026-03-09 | -$8.42M derived: sum of 4 quarters · filed 2026-03-09 | ||
| 2023-12-31 | -$6.29M 10-K · filed 2025-03-07 | -$7.34M derived: sum of 2 quarters · filed 2025-03-07 | -$6.47M derived: sum of 3 quarters · filed 2025-03-07 | -$6.28M 10-K · filed 2025-03-07 | ||
| 2023-09-30 | -$1.05M 10-K · filed 2025-03-07 | -$177.10K derived: sum of 2 quarters · filed 2025-03-07 | $15.09K 10-Q · filed 2024-11-08 | -$2.43M derived: sum of 4 quarters · filed 2025-03-07 | ||
| 2023-06-30 | $872.20K 10-K · filed 2025-03-07 | $1.06M 10-Q · filed 2024-08-09 | -$1.38M derived: sum of 3 quarters · filed 2025-03-07 | -$1.78M derived: sum of 4 quarters · filed 2025-03-07 | ||
| 2023-03-31 | $192.18K 10-K · filed 2025-03-07 | -$2.25M derived: sum of 2 quarters · filed 2025-03-07 | -$2.66M derived: sum of 3 quarters · filed 2025-03-07 | -$3.99M derived: sum of 4 quarters · filed 2025-03-07 | ||
| 2022-12-31 | -$2.44M 10-K · filed 2024-03-13 | -$2.85M derived: sum of 2 quarters · filed 2024-03-13 | -$4.18M derived: sum of 3 quarters · filed 2024-03-13 | -$5.57M 10-K · filed 2024-03-13 | ||
| 2022-09-30 | -$408.64K 10-K · filed 2024-03-13 | -$1.74M derived: sum of 2 quarters · filed 2024-03-13 | -$3.13M 10-Q · filed 2023-11-13 | -$6.98M derived: sum of 4 quarters · filed 2024-03-13 | ||
| 2022-06-30 | -$1.34M 10-K · filed 2024-03-13 | -$2.72M 10-Q · filed 2023-08-11 | -$6.57M derived: sum of 3 quarters · filed 2024-03-13 | -$7.62M derived: sum of 4 quarters · filed 2024-03-13 | ||
| 2022-03-31 | -$1.39M 10-K · filed 2024-03-13 | -$5.23M derived: sum of 2 quarters · filed 2024-03-13 | -$6.29M derived: sum of 3 quarters · filed 2024-03-13 | -$5.06M derived: sum of 4 quarters · filed 2024-03-13 | ||
| 2021-12-31 | -$3.85M 10-K · filed 2023-03-13 | -$4.90M derived: sum of 2 quarters · filed 2023-03-13 | -$3.67M derived: sum of 3 quarters · filed 2023-03-13 | -$3.51M 10-K · filed 2023-03-13 | ||
| 2021-09-30 | -$1.06M 10-K · filed 2023-03-13 | $173.28K derived: sum of 2 quarters · filed 2023-03-13 | $340.11K 10-Q · filed 2022-11-14 | -$543.67K derived: sum of 4 quarters · filed 2023-03-13 | ||
| 2021-06-30 | $1.23M 10-K · filed 2023-03-13 | $1.40M 10-Q · filed 2022-08-12 | $511.61K derived: sum of 3 quarters · filed 2023-03-13 | $29.88K derived: sum of 4 quarters · filed 2023-03-13 | ||
| 2021-03-31 | $166.83K 10-K · filed 2023-03-13 | -$716.95K derived: sum of 2 quarters · filed 2023-03-13 | -$1.20M derived: sum of 3 quarters · filed 2023-03-13 | -$2.12M derived: sum of 4 quarters · filed 2023-03-13 | ||
| 2020-12-31 | -$883.78K 10-K · filed 2022-03-11 | -$1.37M derived: sum of 2 quarters · filed 2022-03-11 | -$2.28M derived: sum of 3 quarters · filed 2022-03-11 | -$3.34M 10-K · filed 2022-03-11 | ||
| 2020-09-30 | -$481.74K 10-K · filed 2022-03-11 | -$1.40M derived: sum of 2 quarters · filed 2022-03-11 | -$2.46M 10-Q · filed 2021-11-12 | -$2.46M 10-Q · filed 2020-11-13 | -$3.42M derived: sum of 4 quarters · filed 2022-03-11 | |
| 2020-06-30 | -$918.27K 10-K · filed 2022-03-11 | -$1.97M 10-Q · filed 2021-08-13 | -$2.93M derived: sum of 3 quarters · filed 2022-03-11 | -$4.89M derived: sum of 4 quarters · filed 2022-03-11 | ||
| 2020-03-31 | -$1.06M 10-K · filed 2022-03-11 | -$2.02M derived: sum of 2 quarters · filed 2022-03-11 | -$3.97M derived: sum of 3 quarters · filed 2022-03-11 | -$4.52M derived: sum of 4 quarters · filed 2022-03-11 | ||
| 2019-12-31 | -$960.71K 10-K · filed 2021-03-12 | -$2.91M derived: sum of 2 quarters · filed 2021-03-12 | -$3.46M derived: sum of 3 quarters · filed 2021-03-12 | -$3.54M 10-K · filed 2022-03-11 | ||
| 2019-09-30 | -$1.95M 10-K · filed 2021-03-12 | -$2.50M derived: sum of 2 quarters · filed 2021-03-12 | -$2.58M 10-Q · filed 2020-11-13 | -$4.80M derived: sum of 4 quarters · filed 2021-03-12 | ||
| 2019-06-30 | -$549.51K 10-K · filed 2021-03-12 | -$623.38K 10-Q · filed 2020-08-14 | -$2.84M derived: sum of 3 quarters · filed 2021-03-12 | -$4.49M derived: sum of 4 quarters · filed 2021-03-12 | ||
| 2019-03-31 | -$73.88K 10-K · filed 2021-03-12 | -$2.29M derived: sum of 2 quarters · filed 2021-03-12 | -$3.94M derived: sum of 3 quarters · filed 2021-03-12 | -$4.66M derived: sum of 4 quarters · filed 2021-03-12 | ||
| 2018-12-31 | -$2.22M 8-K · filed 2020-12-10 | -$3.86M derived: sum of 2 quarters · filed 2020-12-10 | -$4.58M derived: sum of 3 quarters · filed 2020-12-10 | -$6.96M 10-K · filed 2021-03-12 | ||
| 2018-09-30 | -$1.64M 8-K · filed 2020-12-10 | -$2.36M derived: sum of 2 quarters · filed 2020-12-10 | -$4.74M 10-Q · filed 2019-11-13 | -$5.54M derived: sum of 4 quarters · filed 2020-12-10 | ||
| 2018-06-30 | -$720.69K 8-K · filed 2020-12-10 | -$3.10M 10-Q · filed 2019-08-14 | -$3.90M derived: sum of 3 quarters · filed 2020-12-10 | -$4.64M derived: sum of 4 quarters · filed 2020-12-10 | ||
| 2018-03-31 | -$2.38M 8-K · filed 2020-12-10 | -$3.18M derived: sum of 2 quarters · filed 2020-12-10 | -$3.92M derived: sum of 3 quarters · filed 2020-12-10 | -$9.08M derived: sum of 4 quarters · filed 2020-12-10 | ||
| 2017-12-31 | -$800.54K 10-K · filed 2019-03-12 | -$1.54M derived: sum of 2 quarters · filed 2019-03-12 | -$6.70M derived: sum of 3 quarters · filed 2019-03-12 | -$7.98M 8-K · filed 2020-12-10 | ||
| 2017-09-30 | -$743.03K 10-K · filed 2019-03-12 | -$5.90M derived: sum of 2 quarters · filed 2019-03-12 | -$7.18M 10-Q · filed 2018-11-14 | -$7.93M derived: sum of 4 quarters · filed 2019-03-12 | ||
| 2017-06-30 | -$5.16M 10-K · filed 2019-03-12 | -$6.44M 10-Q · filed 2018-08-14 | -$7.18M derived: sum of 3 quarters · filed 2019-03-12 | -$7.08M derived: sum of 4 quarters · filed 2019-03-12 | ||
| 2017-03-31 | -$1.27M 10-K · filed 2019-03-12 | -$2.02M derived: sum of 2 quarters · filed 2019-03-12 | -$1.92M derived: sum of 3 quarters · filed 2019-03-12 | -$1.97M derived: sum of 4 quarters · filed 2019-03-12 | ||
| 2016-12-31 | -$749.69K 10-K · filed 2018-03-09 | -$643.53K derived: sum of 2 quarters · filed 2018-03-09 | -$691.57K derived: sum of 3 quarters · filed 2018-03-09 | -$944.68K 10-K · filed 2019-03-12 | ||
| 2016-09-30 | $106.17K 10-K · filed 2018-03-09 | $58.12K derived: sum of 2 quarters · filed 2018-03-09 | -$194.99K 10-Q · filed 2017-11-08 | -$43.93K derived: sum of 4 quarters · filed 2018-03-09 | ||
| 2016-06-30 | -$48.04K 10-K · filed 2018-03-09 | -$301.15K 10-Q · filed 2017-08-09 | -$150.10K derived: sum of 3 quarters · filed 2018-03-09 | -$23.48K derived: sum of 4 quarters · filed 2018-03-09 | ||
| 2016-03-31 | -$253.11K 10-K · filed 2018-03-09 | -$102.05K derived: sum of 2 quarters · filed 2018-03-09 | $24.56K derived: sum of 3 quarters · filed 2018-03-09 | $431.96K derived: sum of 4 quarters · filed 2018-03-09 | ||
| 2015-12-31 | $151.06K 10-K · filed 2017-03-13 | $277.67K derived: sum of 2 quarters · filed 2017-03-13 | $685.07K derived: sum of 3 quarters · filed 2017-03-13 | $731.35K 10-K · filed 2018-03-09 | ||
| 2015-09-30 | $126.61K 10-K · filed 2017-03-13 | $534.01K derived: sum of 2 quarters · filed 2017-03-13 | $580.29K 10-Q · filed 2016-11-03 | $1.25M derived: sum of 4 quarters · filed 2017-03-13 | ||
| 2015-06-30 | $407.40K 10-K · filed 2017-03-13 | $406.00K 10-Q · filed 2015-08-07 | $452.28K 10-Q · filed 2016-08-05 | $1.12M derived: sum of 3 quarters · filed 2017-03-13 | $1.87M derived: sum of 4 quarters · filed 2017-03-13 | |
| 2015-03-31 | $46.28K 10-K · filed 2017-03-13 | $715.19K derived: sum of 2 quarters · filed 2017-03-13 | $1.46M derived: sum of 3 quarters · filed 2017-03-13 | $2.18M derived: sum of 4 quarters · filed 2017-03-13 | ||
| 2014-12-31 | $668.91K 10-K · filed 2016-03-14 | $1.41M derived: sum of 2 quarters · filed 2016-03-14 | $2.14M derived: sum of 3 quarters · filed 2016-03-14 | $2.42M 10-K · filed 2017-03-13 | ||
| 2014-09-30 | $745.92K 10-K · filed 2016-03-14 | $1.47M derived: sum of 2 quarters · filed 2016-03-14 | $1.75M 10-Q · filed 2015-11-06 | $254.45K derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2014-06-30 | $722.57K 10-K · filed 2016-03-14 | $1.01M 10-Q · filed 2015-08-07 | -$491.47K derived: sum of 3 quarters · filed 2016-03-14 | -$1.31M derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2014-03-31 | $286.32K 10-K · filed 2016-03-14 | -$1.21M derived: sum of 2 quarters · filed 2016-03-14 | -$2.03M derived: sum of 3 quarters · filed 2016-03-14 | -$2.67M derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2013-12-31 | -$1.50M 10-K · filed 2015-03-09 | -$2.32M derived: sum of 2 quarters · filed 2015-03-09 | -$2.96M derived: sum of 3 quarters · filed 2015-03-09 | -$2.10M 10-K · filed 2016-03-14 | ||
| 2013-09-30 | -$819.94K 10-K · filed 2015-03-09 | -$1.46M derived: sum of 2 quarters · filed 2015-03-09 | -$604.25K 10-Q · filed 2014-11-07 | $1.20M derived: sum of 4 quarters · filed 2015-03-09 | ||
| 2013-06-30 | -$639.02K 10-K · filed 2015-03-09 | $215.69K 10-Q · filed 2014-08-08 | $2.02M derived: sum of 3 quarters · filed 2015-03-09 | $3.89M derived: sum of 4 quarters · filed 2015-03-09 | ||
| 2013-03-31 | $854.71K 10-K · filed 2015-03-09 | $2.66M derived: sum of 2 quarters · filed 2015-03-09 | $4.53M derived: sum of 3 quarters · filed 2015-03-09 | $6.27M derived: sum of 4 quarters · filed 2015-03-09 | ||
| 2012-12-31 | $1.81M 10-K · filed 2014-03-11 | $3.67M derived: sum of 2 quarters · filed 2014-03-11 | $5.42M derived: sum of 3 quarters · filed 2014-03-11 | $5.84M 10-K · filed 2015-03-09 | ||
| 2012-09-30 | $1.87M 10-K · filed 2014-03-11 | $3.61M derived: sum of 2 quarters · filed 2014-03-11 | $4.04M 10-Q · filed 2013-11-06 | $4.95M derived: sum of 4 quarters · filed 2014-03-11 | ||
| 2012-06-30 | $1.74M 10-K · filed 2014-03-11 | $2.17M 10-Q · filed 2013-08-09 | $3.08M derived: sum of 3 quarters · filed 2014-03-11 | $4.93M derived: sum of 4 quarters · filed 2014-03-11 | ||
| 2012-03-31 | $423.21K 10-K · filed 2014-03-11 | $1.33M derived: sum of 2 quarters · filed 2014-03-11 | $3.18M derived: sum of 3 quarters · filed 2014-03-11 | $5.36M derived: sum of 4 quarters · filed 2014-03-11 | ||
| 2011-12-31 | $911.66K 10-K · filed 2013-03-12 | $2.76M derived: sum of 2 quarters · filed 2013-03-12 | $4.94M derived: sum of 3 quarters · filed 2013-03-12 | $5.66M 10-K · filed 2014-03-11 | ||
| 2011-09-30 | $1.85M 10-K · filed 2013-03-12 | $4.03M derived: sum of 2 quarters · filed 2013-03-12 | $4.75M 10-Q · filed 2012-11-02 | $5.58M derived: sum of 4 quarters · filed 2013-03-12 | ||
| 2011-06-30 | $2.18M 10-K · filed 2013-03-12 | $2.90M 10-Q · filed 2012-08-09 | $3.74M derived: sum of 3 quarters · filed 2013-03-12 | $4.74M derived: sum of 4 quarters · filed 2013-03-12 | ||
| 2011-03-31 | $721.16K 10-K · filed 2013-03-12 | $1.56M derived: sum of 2 quarters · filed 2013-03-12 | $2.57M derived: sum of 3 quarters · filed 2013-03-12 | $2.85M derived: sum of 4 quarters · filed 2013-03-12 | ||
| 2010-12-31 | $837.55K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $1.85M derived: sum of 2 quarters · filed 2013-03-12 | $2.13M derived: sum of 3 quarters · filed 2013-03-12 | $2.46M 10-K · filed 2013-03-12 | ||
| 2010-09-30 | $1.01M 10-Q · filed 2011-11-07 | $1.30M derived: sum of 2 quarters · filed 2011-11-07 | $1.62M 10-Q · filed 2011-11-07 | |||
| 2010-06-30 | $287.30K 10-Q · filed 2011-08-08 | $610.88K 10-Q · filed 2011-08-08 | ||||
| 2009-12-31 | $3.09M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |